Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana

NCT02593734 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2015-11-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate a bundled intervention of psychotropic drugs and daily contact with a nurse for people with mental health disorders in a prayer camp and secondly to assess whether the attitudes of the prayer camp staff toward mental health disorders and conventional medicines remain the same after the intervention.

Conditions

Interventions

DRUG

olanzapine

oral antipsychotic drug therapy

DRUG

risperidone

oral antipsychotic drug therapy

DRUG

amitryptaline

oral antidepressant drug therapy

DRUG

fluoxetine

oral drug therapy for depression

Sponsors & Collaborators

  • University of Ghana Medical School

    lead OTHER

Principal Investigators

  • Angela L Ofori-Atta, PhD · University of Ghana Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Ghana

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593734 on ClinicalTrials.gov